CMMC Symposium 2026

"Metabolic Control of Tissue Regeneration and Degeneration"
September 28 - 30, 2026

Register now and send your poster abstracts!

CMMC 2026-2028

We research for your health

Gerhard Richter Transparente

CMMC Research Building


National Immunity Platform COVIM Receives Funding as a New Research Infrastructure - Collaborative project initiated by University Hospital Cologne and Charité

16/09/2026 | The COVIM immunity platform (COllaboratiVe IMmunity Platform of the NUM), jointly established and coordinated by the Department of Virology at University Hospital Cologne and the Department of Infectious Diseases at Charité – Universitätsmedizin Berlin, will receive multimillion-euro funding from the German Federal Ministry of Research, Technology and Space as a new nationwide research infrastructure.

Million-Euro Funding to Advance Lymphoma Therapy - ERC Starting Grant for Prof. Dr. Dr. Philipp Schommers

04/09/2026 | Professor Dr. Dr. Philipp Schommers - principle investigator at the CMMC - has been awarded a prestigious Starting Grant from the European Research Council (ERC). The ERC Starting Grant supports outstanding early-career researchers for a period of five years with funding of up to €1.5 million.

SFB 1403 International Symposium on Cell Death

25/08/2026 | The "SFB 1403 International Symposium on Cell Death", organized and hosted by the SFB 1403, will take place on September 23-25, 2026 at the Max Planck Institute of Ageing (Cologne). Registration is open, spots are limited.

New method for investigating the effects of degenerative diseases on individual cells

24/08/2026 | Scientists in Cologne are developing a method to track damage at the level of individual cells. The study opens up new avenues for research into age-related degenerative diseases / publication in ‘Cell Genomics’

Professor Dr Florian Klein: Research is shaping protection against viral diseases

14/08/2026 | Florian Klein is Professor of Virology, Director of the Institute of Virology at University Hospital Cologne and Executive Board Member at the CMMC. He combines basic research on the body’s defence mechanisms with clinical applications, developing highly effective antibodies that improve vaccination strategies and enable new therapeutic approaches.

Research Advancing Precision Medicine for Neuroblastoma

13/08/2026 | PD Dr. Carolina Rosswog from the Department of Experimental Pediatric Oncology at University Hospital Cologne has received €151,200 in research funding from the Marga and Walter Boll Foundation.


Upcoming Seminars

Mobile Life Science Calendar

Scan or tap on the QR Code to install the Life Science Calendar on your mobile device!